Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection

Immunological Reviews

Volumn 183, Issue , 2001, Pages 115-126

  O'Connor, David ^a   Friedrich, Thomas ^a   Hughes, Austin ^a   Allen, Todd M ^a   Watkins, David ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADAPTATION; ANTIGENIC VARIATION; ANTIGENICITY; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; GENE SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONKEY DISEASE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REVIEW; RHESUS MONKEY; SEQUENCE ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS GENOME; VIRUS MUTANT; VIRUS MUTATION; VIRUS PATHOGENESIS;

EID: 0035667633     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2001.1830110.x     Document Type: Review

References (101)

1. SIV infection of macaques: A model for AIDS vaccine development
2. Comparison of simian immunodeficiency virus isolates
3. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus
4. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants
5. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: Persistent infection of rhesus monkeys with molecularly cloned SlVmac
6. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus
7. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys
8. Viral genetic evolution in macaques infected with molecularly cloned simian immunodeficiency virus correlates with the extent of persistent viremia
9. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys
10. Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine
11. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression
12. Macaques infected with cloned simian immunodeficiency virus show recurring nef gene alterations
13. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques
14. Rapid definition of five novel HLA-A*3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by Elispot and intracellular cytokine staining assays
15. HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway
16. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
17. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein
18. Macrophage tropism of human immunodeficiency virus type 1 facilitates in vivo escape from cytotoxic T-lymphocyte pressure
19. Viral immune evasion due to persistence of activated T cells without effector function
20. + T cells during the chronic phase of infection
21. Cellular immune responses to HIV
22. Living in oblivion: HIV immune evasion
23. Cytotoxic T lymphocyte responses to human immunodeficiency virus: Control and escape
24. Fidelity of the RNA-dependent DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency virus types 1 and 2 and of murine leukemia virus: Mispair extension frequencies
25. Fidelity of the reverse transcriptase of human immunodeficiency virus type 2
26. Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase
27. The accuracy of reverse transcriptase from HIV-1
28. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy
29. Genetic drift can dominate short-term human immunodeficiency virus type 1 nef quasispecies evolution in vivo
30. HIV-1 sequence variation: Drift, shift, and attenuation
31. Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: Evidence of minimal genetic drift and low pathogenetic effects
32. Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1
33. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: Constraints on immune escape associated with targeting a sequence essential for viral replication
34. Population dynamics in the evolution of RNA viruses
35. Molecular evolution of the vertebrate immune system
36. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions
37. Estimating synonymous and nonsynonymous substitution rates
38. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo
39. In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes
40. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
41. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: Definition of minimum epitopes and analysis of the effects of sequence variation
42. Cytotoxic T-cell activity antagonized by naturally occurring HIV-I Gag variants
43. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus
44. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses
45. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants
46. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
47. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
48. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
49. Sequence constraints and recognition by CTL of an HLA-B27-restricted HIV-1 gag epitope
50. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load
51. Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1
52. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo
53. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection
54. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection
55. In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity
56. Are RNA viruses adapting or merely changing?
57. Running the gamut of retroviral variation
58. Structural constraints of HIV-1 Nef may curtail escape from HLA-B7-restricted CTL recognition
59. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag
60. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus
61. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I
62. Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine
63. Temporal loss of Nefepitope CTL recognition following macaque lipopeptide immunization and SIV challenge
64. Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: Evidence for an influence on disease progression
65. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
66. HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage
67. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS
68. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
69. Major histocompatibility complex class II DR alleles DRB1*1501 and those encoding HLA-DR13 are preferentially associated with a diminution in maternally transmitted human immunodeficiency virus 1 infection in different ethnic groups: Determination by an automated sequence-based typing method
70. Association of HLA-DQ and -DR alleles with protection from or infection with HIV-1
71. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection
72. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences
73. Subity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides
74. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques
75. A maximum-likelihood approach to analyzing nonoverlapping and overlapping reading frames
76. Stability and evolution of overlapping genes
77. Evolution of overlapping genes
78. Constrained evolution with respect to gene overlap of hepatitis B virus
79. On the informational content of overlapping genes in prokaryotic and eukaryotic viruses
80. Simultaneous positive and purifying selection on overlapping reading frames of the Tat and vpr genes of simian immunodeficiency virus
81. Impact of epitope expression kinetics on the effectiveness of HIV-specific cytotoxic T-lymphocytes
82. High-avidity cytotoxic T-lymphocytes induce rapid viral escape during the acute phase of SIV infection
83. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection
84. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides
85. A comprehensive polymerase chain reactionoligonucleotide typing system for the HLA class I A Locus
86. Loss of viral fitness associated with multiple Gag and Gag-Pol processing defects in human immunodeficiency virus type 1 variants selected for resistance to protease inhibitors in vivo
87. Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: Phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients
88. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
89. Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus
90. Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multidideoxynucleoside resistance
91. Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine
92. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
93. The role of nonhuman primates in the development of an AIDS vaccine
94. The role of nonhuman primate models in AIDS vaccine development
95. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses
96. Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I
97. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
98. Virus dynamics and drug therapy
99. Suboptimal nucleotides in the infectious, pathogenic simian immunodeficiency virus clone SIVmac239